AF was very negative about Amylin/Bydureon in Jan 2012 even after FDA approval. He said that if JnJ, a partner in Amylin since 2000, sold back all rights to Bydureon for 1B$, it can't be worth anything since JNJ is an insider and they must know everything about Bydureon and if they sold back the rights, it must be a dud. BMY bought out Amylin 6 months later for 31$, an increase of 20$.
I agree. That is the job of the Amarin presenters on Adcom day to convey that to the panelists.
If the FDA is going/thinking of non approval for Anchor, they don't need to ask the opinion of any Adcom to do. I have seen it with Bydureon which is exactly the same case of sNDA (of Byetta). AF put that in your bong and smoke it.
you can put him on iggy like I did. or just plain ignore him and his ilk (brig etc ...).why do you insist on dialogue and argument with people who are obviously beyond and not interested in dialog and argument ?
The way I see it, the problem is you and not them.
Btw, I do agree with the derriere back ward way IhubCab is trying to maintain a spam free forum. Ihubcab is free of spam alright, but it is full or disinformation content disguised as personal opinion and tolerated as a matter of free speech.
It's becoming clear to me AF is getting paid to both produce hit pieces based on flimsy and idiotic arguments and to provide a paid for avenue for shorts to talk their book.
He must not get paid enough as a reporter for the street as he should. lol
Don't fall prey to the recency effect like most common retailers. It's a good buy at this level imo. Granted it is hard to pull the trigger when every fiber in your body tells you no. But remember only 1 out 10 (if may that much) will be profitable as a speculator on WS , the rest will end being vig payers. And go with the crowd isn't the way. Buy when they sell and sell when they buy.
Beats me. I just bought 4K more today. Supply and demand drive the day to day fluctuation. If the daily variations unnerves you, perhaps you should get a prescription for something like prozac , not vascepa. lol.
I believe you guys are making a big deal out of nothing (this financing thing). JayZee didn't want to dilute either thru a secondary offering or a convertible debt offering so the only option left is a straight debt. Hence the need for a collateral. The only thing valuables amrn has are patents otherwise what else can they offer up in return for the loans ie 100M$ to be received from the creditors ? How is this different from a mortgage loan a common retailer get when buying a house ? The bank ie the creditor has the title. Your name maybe on the title but you don't have it. The bank has it in case of default. Same here, pure and simple.
Golong, No partnership about Anchor indication until sales are in the Billions, eh? Lol. That is the fear of a real petty short speaking trying to reassure himself, isn't it ? If that is your case, I'm more than willing to take the other side.Bring it on, golong. By the time the smoke is clear, may as well not sell the company.